Literature DB >> 5807872

Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in tumours of the central nervous system.

G A Davies-Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5807872      PMCID: PMC496521          DOI: 10.1136/jnnp.32.4.324

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  14 in total

1.  THE CEREBROSPINAL-FLUID GLUTAMIC OXALOACETIC TRANSAMINASE ACTIVITY IN NEUROLOGICAL DISEASES.

Authors:  R S MELLICK; R L BASSETT
Journal:  Lancet       Date:  1964-04-25       Impact factor: 79.321

2.  Inhibition of dehydrogenase reactions by a substance formed from reduced diphosphopyridine nucleotide.

Authors:  C P FAWCETT; M M CIOTTI; N O KAPLAN
Journal:  Biochim Biophys Acta       Date:  1961-11-25

3.  Effect of prolonged hypoxia on cerebrospinal fluid and plasma activity of GOT and LDH.

Authors:  M LENDING; L B SLOBODY; J MESTERN
Journal:  Neurology       Date:  1961-06       Impact factor: 9.910

4.  Cerebrospinal fluid glutamic oxalacetic transaminase activity in neurologic disease.

Authors:  J B GREEN; H A OLDEWURTEL; D S O'DOHERTY; F M FORSTER; L P SANCHEZ-LONGO
Journal:  Neurology       Date:  1957-05       Impact factor: 9.910

5.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

6.  Glutamic-oxalacetic transaminase and lactic dehydrogenase in serum and cerebrospinal fluid of patients with neurologic disorders.

Authors:  G A FLEISHER; K G WAKIM; N P GOLDSTEIN
Journal:  Proc Staff Meet Mayo Clin       Date:  1957-04-17

7.  Activity of lactic dehydrogenase in spinal fluid.

Authors:  F WROBLEWSKI; B DECKER; R WROBLEWSKI
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

8.  Effect of severe hypoxia on blood-cerebrospinal fluid barrier.

Authors:  L B SLOBODY; D C YANG; M LENDING; F J BORRELLI; M TYREE
Journal:  Am J Physiol       Date:  1957-08

9.  Glutamic-oxalacetic transaminase activity in spinal fluid.

Authors:  R KATZMAN; R A FISHMAN; E S GOLDENSOHN
Journal:  Neurology       Date:  1957-12       Impact factor: 9.910

10.  Lactic dehydrogenase of cerebrospinal fluid in the differential diagnosis of cerebrovascular disease and brain tumor.

Authors:  R K JAKOBY; W B JAKOBY
Journal:  J Neurosurg       Date:  1958-01       Impact factor: 5.115

View more
  4 in total

1.  Lactate dehydrogenase and aspartete transaminase of the cerebrospinal fluid in patients with brain tumours, congenital hydrocephalus, and brain abscess.

Authors:  S R Dharker; R S Dharker; B D Chaurasia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

2.  Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.

Authors:  A Twijnstra; A P van Zanten; A A Hart; B W Ongerboer de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

3.  Changes in lactate dehydrogenase isoenzyme patterns in patients with tumours of the central nervous system.?

Authors:  L Rabow; K Kristensson
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

4.  Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.

Authors:  A Twijnstra; A P van Zanten; W J Nooyen; B W Ongerboer de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.